Antibiotic development - economic, regulatory and societal challenges

Affiliations

¹ Norwegian Institute of Public Health, Oslo, Norway. christine.ardal@fhi.no.
² Global Antibiotic R&D Partnership, Geneva, Switzerland. mbalasegaram@gardp.org.
³ Center for Disease Dynamics, Economics & Policy, Washington, DC, USA. ramanan@cddep.org.
⁴ Fuqua School of Business and Economics Department, Duke University, Durham, NC, USA. mcadams.david@gmail.com.
⁵ Boston University, Boston, MA, USA. mko@bu.edu.
⁶ F2G Ltd, Eccles, UK. john.rex@f2g.com.
⁷ Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand. nithima@fda.moph.go.th.

Review

Christine Årdal et al. Nat Rev Microbiol. 2020 May.

. 2020 May;18(5):267-274.

doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.

¹ Norwegian Institute of Public Health, Oslo, Norway. christine.ardal@fhi.no.
² Global Antibiotic R&D Partnership, Geneva, Switzerland. mbalasegaram@gardp.org.
³ Center for Disease Dynamics, Economics & Policy, Washington, DC, USA. ramanan@cddep.org.
⁴ Fuqua School of Business and Economics Department, Duke University, Durham, NC, USA. mcadams.david@gmail.com.
⁵ Boston University, Boston, MA, USA. mko@bu.edu.
⁶ F2G Ltd, Eccles, UK. john.rex@f2g.com.
⁷ Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand. nithima@fda.moph.go.th.

No abstract available

References

1. Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29 (2007). - DOI
1. Sertkaya, A. et al. Analytical framework for examining the value of antibacterial products. Submitted to the US Department of Health and Human Services https://aspe.hhs.gov/report/analytical-framework-examining-value-antibac... (2014).
1. Årdal, C. et al. Insights into early stage of antibiotic development in small-and medium-sized enterprises: a survey of targets, costs, and durations. J. Pharm. Policy Pract. 11, 8 (2018). - DOI
1. World Health Organization. WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. https://www.who.int/medicines/areas/rational_use/oms-amr-amc-report-2016... (2018).
1. Holmes, A. H. et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387, 176–187 (2016). - DOI